Recruitment Software Market is Poised to Register CAGR of 9.86 percent by 2031 SkyQuest Technology
| AVXL Stock | USD 9.46 0.43 4.76% |
About 61% of all Anavex Life's institutional investors are looking to take a long position. The analysis of the overall investor sentiment regarding Anavex Life Sciences suggests that some traders are interested. Anavex Life's investing sentiment shows overall attitude of investors towards Anavex Life Sciences.
Anavex |
Recruitment Software Market size was valued at USD 2.53 billion in 2022 and is poised to grow from USD 2.78 billion in 2023 to USD 5.89 billion by 2031, growing at a CAGR of 9.86 percent in the forecast period .Westford, USA, Nov. 25, 2024 -- SkyQuest projects that the Recruitment Software Market will reach a value of USD 5.89 Billion by 2031, with a CAGR of 9.86 percent during the forecast period . The increasing popularity in the use of cloud-based platforms and mobile
Read at finance.yahoo.com
 |
Anavex Life Fundamental Analysis
We analyze Anavex Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anavex Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anavex Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Anavex Life is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Anavex Life Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anavex Life stock to make a market-neutral strategy. Peer analysis of Anavex Life could also be used in its relative valuation, which is a method of valuing Anavex Life by comparing valuation metrics with similar companies.
Peers
Anavex Life Related Equities
| INMB | INmune Bio | 3.27 | ||||
| RNAZ | Transcode Therapeutics | 2.94 | ||||
| ANVS | Annovis Bio | 2.60 | ||||
| KOD | Kodiak Sciences | 1.83 | ||||
| EXEL | Exelixis | 1.48 | ||||
| NVAX | Novavax | 1.16 | ||||
| TGTX | TG Therapeutics | 0.57 | ||||
| IOVA | Iovance Biotherapeutics | 0.85 | ||||
| MDGL | Madrigal Pharmaceuticals | 0.98 | ||||
| AXSM | Axsome Therapeutics | 1.44 | ||||
| CGTX | Cognition Therapeutics | 2.44 | ||||
| VKTX | Viking Therapeutics | 2.88 | ||||
| SAVA | Cassava Sciences | 3.52 | ||||
| BIVI | Biovie | 3.90 | ||||
| RVPHW | Reviva Pharmaceuticals | 4.35 | ||||
| BTAI | BioXcel Therapeutics | 8.89 |
Check out Anavex Life Hype Analysis, Anavex Life Correlation and Anavex Life Performance. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.